Shinya Goto: DOAC vs Placebo in Intermediate Stroke Risk of AF in Single Country?
Shinya Goto, Director and Chairman in Metabolic Disease Research Center, shared a post on LinkedIn about a recent article by Daehoon Kim et al., published in The New England Journal of Medicine, adding:
“DOAC vs placebo in intermediate stroke risk of AF in single country?
Primary endpoint is combined safety or efficacy. NEJM shifted more for practice than keeping science?”
Title: Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk
Authors: Daehoon Kim, Young Soo Lee, Jaemin Shim, Hee Tae Yu, Junbeom Park, Jin-Kyu Park, Il-Young Oh, Ki-Woon Kang, Eue-Keun Choi, Kyoung-Min Park, Hyoung-Seob Park, Dae-Hyeok Kim, Hyung Wook Park, Jun Kim, Jum-Suk Ko, Dongmin Kim, Jong-Youn Kim, Jin-Bae Kim, Jung-Hoon Sung, Tae-Hoon Kim, Jae-Sun Uhm, Hui-Nam Pak, Boyoung Joung
Other posts featuring Shinya Goto on Hemostasis Today.
-
Nov 12, 2026, 22:52Milka Koupenova: The Role of Platelet RIG-I in Regulating Thrombotic Responses
-
Nov 12, 2026, 22:50Arun V J: Why Has India Still Not Achieved 100% Voluntary Blood Donation?
-
Nov 12, 2026, 22:49Sickle Cell Disease Deserves to Be Prioritised in Ghana – ISCC
-
Nov 12, 2026, 22:47Samir Kumar Beura: Delighted to Serve as a Topic Editor for a Research Topic in Frontiers in Neuroscience
-
Nov 12, 2026, 22:46Ashish Sharma: In-Hospital Mortality and Bleeding Complications in APL
-
Nov 12, 2026, 22:44Mary Cushman: New Position at the Vermont Center for Cardiovascular and Brain Health
-
Nov 12, 2026, 22:43Lama Alstanbuli: Discussing and Optimizing Stroke Pathways Across Healthcare Systems
-
Nov 12, 2026, 22:35Carmen’s Recovery From Spontaneous Coronary Artery Dissection – American Heart Association
-
Nov 12, 2026, 22:34What’s Next in Comprehensive Care for Hemophilia and Other Bleeding Disorders? – WFH